Generic and Biosimilar Cancer Medicines

View buyer

Estimated value

goods

Awarded value

Suppliers

67

1 SME

Lots

33

33 awarded

Published

21 Apr 2023

Total lots

33

Awarded

33

0 pending

Estimated total

£56.5m

Awarded total

Lot 1cancelled

Lot 1 Bendamustine Powder For Solution For Infusion

Award value

Start

End

Estimated

£95k

CPV

33600000
Awarded to 1 supplier
Lot 2cancelled

Lot 2 Capecitabine Tablets

Award value

Start

End

Estimated

£911k

CPV

33600000
Awarded to 1 supplier
Lot 3cancelled

Lot 3 Carboplatin Injection

Award value

Start

End

Estimated

£597k

CPV

33600000
Awarded to 1 supplier
Lot 4cancelled

Lot 4 Cisplatin Injection

Award value

Start

End

Estimated

£186k

CPV

33600000
Awarded to 1 supplier
Lot 5cancelled

Lot 5 Cyclophosphamide Injection, Powder For Reconstitution

Award value

Start

End

Estimated

£267k

CPV

33600000
Awarded to 1 supplier
Lot 6cancelled

Lot 6 Cytarabine Injections

Award value

Start

End

Estimated

£105k

CPV

33600000
Awarded to 1 supplier
Lot 7cancelled

Lot 7 Dacarbazine Injections

Award value

Start

End

Estimated

£593k

CPV

33600000
Awarded to 1 supplier
Lot 8cancelled

Lot 8 Disodium Folinate Injection

Award value

Start

End

Estimated

£442k

CPV

33600000
Awarded to 1 supplier
Lot 9cancelled

Lot 9 Docetaxel Concentrate For Solution For Infusion

Award value

Start

End

Estimated

£333k

CPV

33600000
Awarded to 1 supplier
Lot 10cancelled

Lot 10 Doxorubicin Hydrochloride Injections

Award value

Start

End

Estimated

£60k

CPV

33600000
Awarded to 1 supplier
Lot 12cancelled

Lot 12 Fluorouracil 50MG/ML Injection

Award value

Start

End

Estimated

£236k

CPV

33600000
Awarded to 1 supplier
Lot 13cancelled

Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Award value

Start

End

Estimated

£109k

CPV

33600000
Awarded to 1 supplier
Lot 14cancelled

Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Award value

Start

End

Estimated

£18k

CPV

33600000
Awarded to 1 supplier
Lot 17cancelled

Lot 17 Ifosfamide Injection Powder For Reconstitution

Award value

Start

End

Estimated

£2.7m

CPV

33600000
Awarded to 1 supplier
Lot 18cancelled

Lot 18 Irinotecan Hydrochloride Injection

Award value

Start

End

Estimated

£248k

CPV

33600000
Awarded to 1 supplier
Lot 19cancelled

Lot 19 Lanreotide Injection Prefilled Syringes

Award value

Start

End

Estimated

£4.7m

CPV

33600000
Awarded to 1 supplier
Lot 20cancelled

Lot 20 Methotrexate Without Preservatives Injection

Award value

Start

End

Estimated

£305k

CPV

33600000
Awarded to 1 supplier
Lot 21cancelled

Lot 21 Methotrexate Oral Solution

Award value

Start

End

Estimated

£56k

CPV

33600000
Awarded to 1 supplier
Lot 23cancelled

Lot 23 Oxaliplatin Vial Solution

Award value

Start

End

Estimated

£209k

CPV

33600000
Awarded to 1 supplier
Lot 24cancelled

Lot 24 Paclitaxel Concentrate For Intravenous Infusion

Award value

Start

End

Estimated

£407k

CPV

33600000
Awarded to 1 supplier
Lot 25cancelled

Lot 25 Temozolomide Capsules

Award value

Start

End

Estimated

£146k

CPV

33600000
Awarded to 1 supplier
Lot 26cancelled

Lot 26 Vincristine Without Preservatives Injection

Award value

Start

End

Estimated

£71k

CPV

33600000
Awarded to 1 supplier
Lot 27cancelled

Lot 27 Vinorelbine Injection

Award value

Start

End

Estimated

£54k

CPV

33600000
Awarded to 1 supplier
Lot 28cancelled

Lot 28 Aprepitant Capsules

Award value

Start

End

Estimated

£116k

CPV

33600000
Awarded to 1 supplier
Lot 31cancelled

Lot 31 Octreotide Injection

Award value

Start

End

Estimated

£167k

CPV

33600000
Awarded to 1 supplier
Lot 32cancelled

Lot 32 Filgrastim Pre-Filled Syringe

Award value

Start

End

Estimated

£1.6m

CPV

33600000
Awarded to 1 supplier
Lot 33cancelled

Lot 33 Pemetrexed Powder For Solution For Infusion Vials

Award value

Start

End

Estimated

£198k

CPV

33600000
Awarded to 1 supplier
Lot 34cancelled

Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials

Award value

Start

End

Estimated

£212k

CPV

33600000
Awarded to 1 supplier
Lot 38cancelled

Lot 38 Dasatinib Tablets

Award value

Start

End

Estimated

£143k

CPV

33600000
Awarded to 2 suppliers
Lot 39cancelled

Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines

Award value

Start

End

Estimated

£10.5m

CPV

33600000
Lot 37cancelled

Lot 37 Etoposide Injection

Award value

Start

End

Estimated

£168k

CPV

33600000
Lot 40cancelled

Lot 40 Idarubicin Hydrochloride Solution for Infusion

Award value

Start

End

Estimated

£13k

CPV

33600000
Awarded to 1 supplier
Lot 41cancelled

Lot 41 Single Supplier Generic Medicines

Award value

Start

End

Estimated

£30.4m

CPV

33600000